Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation
- PMID: 19213682
- DOI: 10.1056/NEJMoa0802905
Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation
Abstract
Infection with the human immunodeficiency virus type 1 (HIV-1) requires the presence of a CD4 receptor and a chemokine receptor, principally chemokine receptor 5 (CCR5). Homozygosity for a 32-bp deletion in the CCR5 allele provides resistance against HIV-1 acquisition. We transplanted stem cells from a donor who was homozygous for CCR5 delta32 in a patient with acute myeloid leukemia and HIV-1 infection. The patient remained without viral rebound 20 months after transplantation and discontinuation of antiretroviral therapy. This outcome demonstrates the critical role CCR5 plays in maintaining HIV-1 infection.
2009 Massachusetts Medical Society
Comment in
-
Not an HIV cure, but encouraging new directions.N Engl J Med. 2009 Feb 12;360(7):724-5. doi: 10.1056/NEJMe0810248. N Engl J Med. 2009. PMID: 19213687 No abstract available.
-
HIV "cure": A shot in the arm?EBioMedicine. 2019 Apr;42:3-5. doi: 10.1016/j.ebiom.2019.04.011. Epub 2019 Apr 11. EBioMedicine. 2019. PMID: 30982768 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials